[{"Assets_0_FY_USD":33707000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1671000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1680000000.0,"RevenuesConverted_1_FY_USD":5243000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":2850000000.0,"EarningsPerShareDiluted_4_FY_USD":2.65,"EarningsPerShareDiluted_1_FY_USD":0.53,"EarningsPerShareBasic_4_FY_USD":2.67,"EarningsPerShareBasic_1_FY_USD":0.53,"CommonStockSharesConverted_0_FY_shares":2200000000.0,"StockholdersEquity_0_FY_USD":16177000000.0,"NetIncomeLossConverted_4_FY_USD":4457000000.0,"NetIncomeLossConverted_1_FY_USD":894000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":1.53,"CommonStockDividendsPerShareDeclared_1_FY_USD":0.39,"StockholdersEquityConverted_0_FY_USD":16347000000.0,"RevenuesConverted_4_FY_USD":17702000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170221"}]